In this video, Leslie Boyd, MD, director of gynecology at NYC Health + Hospitals/Bellevue, discusses the impact of cervical cancer on patients’ quality of life.

Patient-reported outcomes from the OUTBACK trial highlight common, persistent sexual side effects that should be addressed following cervical cancer treatment.

Hera Biotech, the leader in definitive, non-invasive women’s health detection and staging for endometriosis, announced today its acquisition of HeraFem®, a p ...

Participation in a cervical cancer screening program in a safety-net health system more than doubled when patients received at-home test kits by mail rather than just a telephone reminder to get ...

Akeso's Cadonilimab Gets NMPA Approval For First-line Cervical Cancer Treatment June 04, 2025 — 09:49 pm EDT Written by RTTNews.com for RTTNews -> ...

Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations—Third Approved Indication for Cadonilimab ...

Circulating tumor DNA (ctDNA) levels in patients with cervical cancer before and during treatment were prognostic of disease progression and survival in a post hoc analysis of the phase 3 CALLA ...

Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab By Akeso, Inc.

Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab By Akeso, Inc.

The family of a 4-year-old girl with a severe medical condition, who has been living in the U.S. legally for two years, is in a struggle to save their daughter’s life since being ordered to self ...

The U.S. Food and Drug Administration has approved the country’s first at-home HPV screening device. The test is designed as an alternative to the Pap smear, a procedure that detects precancerous ...

MINNEAPOLIS — Fewer than half of women treated for high-grade cervical dysplasia subsequently received guidance-concordant surveillance, of whom one-third had an abnormal co-test result ...